EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2010 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 14th, 2010 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 2nd day of February, 2010, to be effective on the 16th day of March, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: Chairman of the Board, and June S. Almenoff, MD, PhD (“Employee”), an individual whose mailing address for notice purposes is 2804 Trail Wood Drive, Durham, North Carolina 27705.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2010 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 14th, 2010 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 12th day of February, 2010, to be effective on the 1st day of April, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: President, and Gail McIntyre (“Employee”), an individual whose mailing address for notice purposes is 2529 Quail Run, Lansdale, Pennsylvania 19446.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2010 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 14th, 2010 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 29th day of January, 2010, to be effective on the 29th day of January, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: President, and Marshall Woodworth (“Employee”), an individual whose mailing address for notice purposes is 503 Middenhall Way, Cary, North Carolina 27513.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2010 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 14th, 2010 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 15th day of January, 2010, to be effective on the 15th day of January, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: President, and Paul S. Covington, MD (“Employee”), an individual whose mailing address for notice purposes is 3116 Braemar Lane, Wilmington, North Carolina 28409.
Portions of this exhibit marked [*] are requested to be treated confidentially. EMPLOYMENT AGREEMENTEmployment Agreement • February 24th, 2010 • Furiex Pharmaceuticals, Inc. • North Carolina
Contract Type FiledFebruary 24th, 2010 Company JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 12th day of February, 2010, to be effective on the 1st day of April, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: President, and Gail McIntyre (“Employee”), an individual whose mailing address for notice purposes is 2529 Quail Run, Lansdale, Pennsylvania 19446.
Portions of this exhibit marked [*] are requested to be treated confidentially. EMPLOYMENT AGREEMENTEmployment Agreement • February 24th, 2010 • Furiex Pharmaceuticals, Inc. • North Carolina
Contract Type FiledFebruary 24th, 2010 Company JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 29th day of January, 2010, to be effective on the 29th day of January, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: President, and Marshall Woodworth (“Employee”), an individual whose mailing address for notice purposes is 503 Middenhall Way, Cary, North Carolina 27513.
Portions of this exhibit marked [*] are requested to be treated confidentially. EMPLOYMENT AGREEMENTEmployment Agreement • February 24th, 2010 • Furiex Pharmaceuticals, Inc. • North Carolina
Contract Type FiledFebruary 24th, 2010 Company JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 15th day of January, 2010, to be effective on the 15th day of January, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: President, and Paul S. Covington, MD (“Employee”), an individual whose mailing address for notice purposes is 3116 Braemar Lane, Wilmington, North Carolina 28409.
Portions of this exhibit marked [*] are requested to be treated confidentially. EMPLOYMENT AGREEMENTEmployment Agreement • February 24th, 2010 • Furiex Pharmaceuticals, Inc. • North Carolina
Contract Type FiledFebruary 24th, 2010 Company JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 2nd day of February, 2010, to be effective on the 16th day of March, 2010 (the “Effective Date”), by and between PPD Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal place of business in North Carolina and currently with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: Chairman of the Board, and June S. Almenoff, MD, PhD (“Employee”), an individual whose mailing address for notice purposes is 2804 Trail Wood Drive, Durham, North Carolina 27705.